Myron F. Kanik

Pembina Pipeline Income Fund operates as a closed-end investment fund. It operates in three segments, which include Conventional Pipelines, Midstream and Marketing & Oil Sands and Heavy Oil. Its Conventional Pipelines segment's objective is to generate sustainable operating margins while pursuing opportunities for increased throughput and revenue enhancements. The company's Midstream and Marketing segment's operations include gas processing, product storage terminalling and hub services. The company's Oil Sands and Heavy Oil segment is characterized by fully contracted service and providing long–term returns which Pembina designed to produce a secure stream of stable cash flow. The company was founded on September 4th, 1997 and is headquartered in Calgary, AB.

AltaGas Income Trust is a closed end income trust. The Trust creates value by acquiring, growing and optimizing gas and power infrastructure, including a focus on renewable energy sources. The company physically gathers processes, extracts and transports natural gas, contractually markets and transports natural gas and electrical power, converts energy across and along the energy value chain to create higher value-added products. The Trust develops its asset base by seeking opportunities for expansion and acquisition in the natural gas, natural gas liquids and power businesses in Canada and the northern United States.

AltaGas Services, Inc. was into the business of producing and marketing natural gas and electrical power. The firm was headquartered in Calgary, Canada.

Part of AltaGas Ltd., Altagas General Partner, Inc. is a Canadian company.

Calgary Health Region provides health programs, healthcare support services, doctor search services, and support programs. The private company is based in Calgary, Canada. and has subsidiaries in Canada.

The Canadian Energy Pipeline Association is a domain that is currently for sale. The non-profit company does not have a physical location or any information about its operations. The website, cepa.com, is available for purchase for USD$6,999.00. Christopher John Charles Bloomer has not been mentioned in the provided metadata.